Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Chemical Science
|
August 30, 2018
On the prevalence of bridged macrocyclic pyrroloindolines formed in regiodivergent alkylations of tryptophan
Tristin E Rose, Brice H Curtin, Kenneth V Lawson, et al.
Archives of Disease in Childhood
|
July 1, 1995
Impact of functional severity on self concept in young people with spina bifida
P E Minchom, N C Ellis, P L Appleton, et al.
Organic Letters
|
January 13, 2025
Stereodivergent Synthesis of the Vicinal Difluorinated Tetralin of Casdatifan Enabled by Ru-Catalyzed Transfer Hydrogenation
Guillaume Mata, Artur K Mailyan, Jeremy Fournier, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1991
Is intraperitoneal tobramycin ototoxic in CAPD patients?
P Nikolaidis, S Vas, V Lawson, et al.
Journal of the American Chemical Society
|
September 12, 2007
Design of emission ratiometric metal-ion sensors with enhanced two-photon cross section and brightness
S Sumalekshmy, Maged M Henary, Nisan Siegel, et al.
British Journal of Pharmacology
|
May 22, 2025
Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcription
Patrick G Schweickert, Dana Piovesan, Casey G Mitchell, et al.
Journal of Medicinal Chemistry
|
January 5, 2021
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors
Ehesan U Sharif, Jaroslaw Kalisiak, Kenneth V Lawson, et al.
Journal of Medicinal Chemistry
|
March 28, 2020
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73
Joel W Beatty, Erick A Lindsey, Rhiannon Thomas-Tran, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2α
Guillaume Mata, Artur K Mailyan, Samuel L Drew, et al.
Journal of Medicinal Chemistry
|
July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73
Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Chemical Science
|
August 30, 2018
On the prevalence of bridged macrocyclic pyrroloindolines formed in regiodivergent alkylations of tryptophan
Tristin E Rose, Brice H Curtin, Kenneth V Lawson, et al.
Archives of Disease in Childhood
|
July 1, 1995
Impact of functional severity on self concept in young people with spina bifida
P E Minchom, N C Ellis, P L Appleton, et al.
Organic Letters
|
January 13, 2025
Stereodivergent Synthesis of the Vicinal Difluorinated Tetralin of Casdatifan Enabled by Ru-Catalyzed Transfer Hydrogenation
Guillaume Mata, Artur K Mailyan, Jeremy Fournier, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1991
Is intraperitoneal tobramycin ototoxic in CAPD patients?
P Nikolaidis, S Vas, V Lawson, et al.
Journal of the American Chemical Society
|
September 12, 2007
Design of emission ratiometric metal-ion sensors with enhanced two-photon cross section and brightness
S Sumalekshmy, Maged M Henary, Nisan Siegel, et al.
British Journal of Pharmacology
|
May 22, 2025
Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcription
Patrick G Schweickert, Dana Piovesan, Casey G Mitchell, et al.
Journal of Medicinal Chemistry
|
January 5, 2021
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors
Ehesan U Sharif, Jaroslaw Kalisiak, Kenneth V Lawson, et al.
Journal of Medicinal Chemistry
|
March 28, 2020
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73
Joel W Beatty, Erick A Lindsey, Rhiannon Thomas-Tran, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2α
Guillaume Mata, Artur K Mailyan, Samuel L Drew, et al.
Journal of Medicinal Chemistry
|
July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73
Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.
Page
of 4